No Waivers, Releases or Amendments. Seller has not granted any material waiver under the Sale Agreement or the Marketing Agreement or released Vertical, in whole or in part, from any of its material obligations under the Sale Agreement or the Marketing Agreement. There have been no oral waivers or modifications (or pending requests therefor) in respect of the Sale Agreement or the Marketing Agreement by Seller or Vertical. Seller has not received from Vertical any proposal, and has not made any proposal to Vertical, to amend or waive any provision of the Sale Agreement or the Marketing Agreement.
No Waivers, Releases or Amendments. Seller has not granted any material waiver under the Sale Agreement or released Medexus, in whole or in part, from any of its material obligations under the Sale Agreement. There are no oral waivers or modifications (or pending requests therefor) in respect of the Sale Agreement. Seller has not received from Medexus any proposal, and has not made any proposal to Medexus, to amend or waive any provision of the Sale Agreement.
No Waivers, Releases or Amendments. Seller (i) has not granted any material written waiver or, to the Knowledge of Seller, any other material waiver, under the License Agreement, (ii) has not granted any waiver under the License Agreement related to, or involving, any Royalty Payments or any Royalty Deductions and (iii) has not released the Licensee, in whole or in part, from any of its material obligations under the License Agreement, except, in each case of the immediately foregoing clauses (i), (ii) and (iii), to the extent set forth in the License Agreement. Since [****], Seller has not received from the Licensee or its Affiliates any written proposal, and has not made any proposal to the Licensee or its Affiliates, to amend or waive any provision of the License Agreement.
No Waivers, Releases or Amendments. In each case, to the extent related to or involving Zolgensma, Seller (i) has not granted any material written waiver or, to the Knowledge of Seller, any other material waiver, under the GSK Agreement, and (ii) has not released GSK, in whole or in part, from any of its material obligations under the GSK Agreement, except, in each case of the immediately foregoing clauses (i) and (ii), to the extent set forth in the GSK Agreement. Since [****], Seller has not received from GSK any written proposal, and has not made any proposal to GSK, to amend or waive any provision of the GSK Agreement, to the extent related to or involving Zolgensma.
No Waivers, Releases or Amendments. In each case, to the extent related to or involving Zolgensma, Seller (i) has not granted any material written waiver or, to the Knowledge of Seller, any other material waiver, under the Penn Agreement, and (ii) has not released Penn, in whole or in part, from any of its material obligations under the Penn Agreement, except, in each case of the immediately foregoing clauses (i) and (ii), to the extent set forth in the Penn Agreement. Since [****], Seller has not received from Penn any written proposal, and has not made any proposal to Penn, to amend or waive any provision of the Penn Agreement, to the extent related to or involving Zolgensma.
No Waivers, Releases or Amendments. Seller has not granted any material waiver under the License Agreement and has not released the Licensee, in whole or in part, from any of its material obligations under the License Agreement, including its obligation to pay Relevant Royalty Payments in accordance with the terms of the License Agreement. Since February 10, 2023 (which is the date of the 2023 Letter Agreement), Seller has not received from the Licensee any written proposal, and has not made any proposal to the Licensee, to amend or waive any provision of the License Agreement.
No Waivers, Releases or Amendments. Seller has not (i) granted any material waiver under the License Agreement (except as provided in the Settlement Agreement with respect to the dismissal of the Action (as defined in the Settlement Agreement)), (ii) granted any waiver under the License Agreement relating to, or involving or otherwise affecting, any Royalty Payments, any Specified Milestone Payments or any Royalty-Milestone Deductions, or (iii) released the Licensee, in whole or in part, from any of its payment obligations in respect of the Royalty Payments or the Specified Milestone Payments or from any of its other material obligations under the License Agreement relating to, or involving or otherwise affecting, any Royalty Payments or any Specified Milestone Payments. Seller has not received from the Licensee any currently pending written proposal, and has not made any currently pending proposal to the Licensee, to amend, waive, supplement or otherwise modify any provision of the License Agreement. Since March 10, 2014, the License Agreement has not been amended, supplemented or otherwise modified pursuant to Section 15.9 of the License Agreement or otherwise, except as set forth in Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4 and the Licensee Letter Agreement.
No Waivers, Releases or Amendments. The Seller has not granted any material waiver under the License Agreement and has not released Licensee, in whole or in part, from any of its respective material obligations under any of the Assigned Agreements. The Seller has not received from Licensee any written proposal, and has not made any proposal to Licensee, to amend or waive any provision of any of the Assigned Agreements.
No Waivers, Releases or Amendments. Seller has not granted any material waiver of any Surviving Obligation under the License Agreement or released Pfizer, in whole or in part, from any of its Surviving Obligations. There are no oral waivers or modifications (or pending requests therefor) in respect of any Surviving Obligation under the License Agreement. Since June 22, 2012, Seller has not received from Pfizer any proposal, and has not made any proposal to Pfizer, to amend or waive any Surviving Obligation under the License Agreement.
No Waivers, Releases or Amendments. Other than the waivers and releases explicitly provided for in the Settlement Agreement: (A) the Seller has not granted any material waiver under the License Agreement or the Settlement Agreement and has not released Jxxxxxx, in whole or in part, from any of its respective material obligations under either of the License Agreement or the Settlement Agreement; and (B) the Seller has not received from Jxxxxxx any written proposal, and has not made any proposal to Jxxxxxx, to amend or waive any provision of either of the License Agreement or the Settlement Agreement.
